MedTrace Logo

Transvaginal Ultrasound and Photoacoustic Imaging of Ovary

NCT04178018 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 185

Last updated 2026-05-08

No results posted yet for this study

Summary

This study is being conducted to validate if photoacoustic imaging potentially reduces benign surgeries without compromising cancer detection sensitivity. The study will also explore whether using the photoacoustic imaging/ultrasound technique has any potential with early ovarian cancer detection in a group of high risk patients.

Conditions

  • Ovary; Anomaly

Interventions

DEVICE

Photoacoustic imaging

-Emerging technique in which a short-pulsed laser beam penetrates diffusively into a tissue sample

DEVICE

Ultrasound

-The ultrasound is being used in conjunction with the photoacoustic imaging

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Cary L Siegel, M.D. · Washington University School of Medicine

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-09
Primary Completion
2026-03-09
Completion
2026-03-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04178018 on ClinicalTrials.gov